BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 18063192)

  • 1. Transfusion transmission of human prion diseases.
    Zou S; Fang CT; Schonberger LB
    Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
    Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
    Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
    Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
    Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
    Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
    Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
    Ironside JW; Head MW
    Haemophilia; 2004 Oct; 10 Suppl 4():64-9. PubMed ID: 15479374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease and blood transfusion.
    Fernandez Lopez MJ; Van Everbroeck B; Pals P; Martin JJ; Cras P
    Acta Neurol Belg; 1998 Sep; 98(3):247-51. PubMed ID: 9801705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.
    Brown P
    Haemophilia; 2007 Dec; 13 Suppl 5():33-40. PubMed ID: 18078395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA; Turner ML
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures.
    Hamaguchi T; Noguchi-Shinohara M; Nozaki I; Nakamura Y; Sato T; Kitamoto T; Mizusawa H; Yamada M
    Neuropathology; 2009 Oct; 29(5):625-31. PubMed ID: 19659942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can prion diseases be transmitted between individuals via blood transfusion: evidence from sheep experiments.
    Hunter N; Houston F
    Dev Biol (Basel); 2002; 108():93-8. PubMed ID: 12220147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prions in dentistry--what are they, should we be concerned, and what can we do?
    Azarpazhooh A; Leake JL
    J Can Dent Assoc; 2006 Feb; 72(1):53-60. PubMed ID: 16480606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of prion disease transmission from ocular donor tissue transplantation.
    Hogan RN; Brown P; Heck E; Cavanagh HD
    Cornea; 1999 Jan; 18(1):2-11. PubMed ID: 9894930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prions and transfusion medicine.
    Budka H
    Vox Sang; 2000; 78 Suppl 2():231-8. PubMed ID: 10938959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
    Urwin PJ; Mackenzie JM; Llewelyn CA; Will RG; Hewitt PE
    Vox Sang; 2016 May; 110(4):310-6. PubMed ID: 26709606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk.
    Crowder LA; Schonberger LB; Dodd RY; Steele WR
    Transfusion; 2017 Aug; 57(8):1875-1878. PubMed ID: 28444687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current strategies to prevent transmission of prions by human plasma derivatives.
    Burnouf T; Padilla A
    Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of accidental transmission of transmissible spongiform encephalopathy: identification of emerging issues.
    Ramasamy I
    Public Health; 2004 Sep; 118(6):409-20. PubMed ID: 15313594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard?
    Sutton JM; Dickinson J; Walker JT; Raven ND
    Clin Infect Dis; 2006 Sep; 43(6):757-64. PubMed ID: 16912952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
    Peden AH; Ritchie DL; Ironside JW
    Folia Neuropathol; 2005; 43(4):271-8. PubMed ID: 16416391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products.
    Millar CM; Makris M
    Br J Haematol; 2012 Aug; 158(4):442-52. PubMed ID: 22775486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.